On the path to 2025: understanding the Alzheimer’s disease continuum

On the path to 2025: understanding the Alzheimer’s disease continuum

Abstract Basic research advances in recent years have furthered our understanding of the natural history of Alzheimer’s disease (AD). It is now recognized that pathophysiological changes begin many years prior to clinical manifestations of disease and the spectrum of AD spans from clinically asympto...

Full description

Bibliographic Details
Main Authors: Paul S. Aisen, Jeffrey Cummings, Clifford R. Jack, John C. Morris, Reisa Sperling, Lutz Frölich, Roy W. Jones, Sherie A. Dowsett, Brandy R. Matthews, Joel Raskin, Philip Scheltens, Bruno Dubois
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Amyloid beta
Biomarker
Cognitive impairment
Clinical
Continuum
Online Access:http://link.springer.com/article/10.1186/s13195-017-0283-5

Internet

http://link.springer.com/article/10.1186/s13195-017-0283-5

Similar Items